Possible Merger for Rorer: Rorer Group Inc....
- Share via
From Times Staff and Wire Reports
Possible Merger for Rorer: Rorer Group Inc. said it is negotiating the sale of 68% of the company for about $73 a share to an unnamed suitor. The Ft. Washington, Pa.-based firm is a pharmaceutical company whose best-known product is Maalox, the No. 1-selling antacid. The unnamed suitor would also “obtain substantial representation” on Rorer’s board, the company said. The deal values all of Rorer at about $3 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
